A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis
Clinical trial NCT05382819 · TERMINATED
Trial details
- NCT number
- NCT05382819
- Sponsor
- Fresh Tracks Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-16
- Primary completion
- 2023-02-08
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.